Hospital
DLP Conemaugh Meyersdale Medical Center LLC
DLP Conemaugh Meyersdale Medical Center LLC was paid $411K by Medicaid between Jul 2020 and Nov 2024, across 55 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 26% of everything it billed.
33Billing provider infoDLP CONEMAUGH MEYERSDALE MEDICAL CENTER LLC
MEYERSDALE, PA 15552
MEYERSDALE, PA 15552
33aNPI1659376358assigned 06/17/2005
33bProvider typeCritical Access Hospital
28Total paid$411K
24GClaims16,921
24DCodes billed55
24AFirst – last monthJul 2020 – Nov 2024
Compared with peers
Next to other Critical Access Hospital providers in Pennsylvania
Rank by total paid#10 of 12
Median peer was paid$1.19M
This provider vs. median0.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official LAWRENCE, CHARLOTTE controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 1,429 | $39K | |
| 2021 | 11,235 | $292K | |
| 2022 | 1,852 | $44K | |
| 2023 | 1,431 | $17K | |
| 2024incomplete | 974 | $19K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 26% | 1,082 | 1,013 | $105K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 18% | 997 | 928 | $76K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 8.0% | 337 | 301 | $33K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 7.5% | 254 | 219 | $31K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 5.1% | 226 | 215 | $21K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 3.7% | 986 | 923 | $15K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 3.5% | 947 | 894 | $14K |
| 80053 | Comprehensive metabolic panel | 3.4% | 1,214 | 1,101 | $14K |
| 36415 | Collection of venous blood by venipuncture | 2.6% | 3,695 | 3,089 | $11K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.2% | 231 | 221 | $9K |
| 80061 | Lipid panel | 2.0% | 570 | 559 | $8K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.9% | 221 | 208 | $8K |
43 more codes
| 80050 | General health panel | 1.9% | 154 | $8K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.7% | 427 | $7K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.7% | 1,288 | $7K |
| 84443 | Thyroid stimulating hormone (TSH) | 1.2% | 207 | $5K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 1.0% | 254 | $4K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 44 | $3K |
| 93000 | <1% | 193 | $3K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 76 | $3K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 186 | $3K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 341 | $2K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 181 | $2K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 317 | $2K |
| 84484 | <1% | 276 | $2K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 16 | $2K |
| 83605 | <1% | 196 | $1K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 132 | $1K |
| 83690 | <1% | 205 | $967.46 | |
| 84439 | <1% | 98 | $897.76 | |
| 71045 | Radiologic examination, chest; single view | <1% | 141 | $880.26 |
| 85027 | <1% | 83 | $725.64 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 97 | $703.16 |
| 81001 | <1% | 244 | $702.54 | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 15 | $611.49 |
| 85610 | <1% | 173 | $610.53 | |
| 84703 | <1% | 52 | $585.01 | |
| 87081 | <1% | 85 | $511.62 | |
| 85379 | <1% | 48 | $509.81 | |
| 81003 | <1% | 138 | $453.03 | |
| 83880 | <1% | 14 | $417.32 | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 34 | $386.19 |
| 87807 | <1% | 24 | $370.21 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 173 | $313.56 |
| 85730 | <1% | 29 | $169.11 | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 32 | $145.44 |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 12 | $144.63 |
| 82043 | <1% | 16 | $130.00 | |
| 82570 | <1% | 16 | $116.22 | |
| 82550 | <1% | 13 | $93.62 | |
| 83735 | <1% | 15 | $93.03 | |
| 85651 | <1% | 12 | $39.06 | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 74 | $27.77 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 14 | $3.64 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 16 | $0.84 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLAWRENCE, CHARLOTTE (SECRETARY)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.